<?xml
version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel xml:lang="fr">
	<title>Joseph Larmarange</title>
	<link>https://joseph.larmarange.net/</link>
	<description>D&#233;mographe en sant&#233; publique, directeur de recherche HDR &#224; l'IRD,directeur adjoint du Ceped (UMR 196 Universit&#233; Paris Cit&#233;, IRD, Universit&#233; Sorbonne Paris Nord, Inserm)</description>
	<language>fr</language>
	<generator>SPIP - www.spip.net</generator>
	<atom:link href="https://www.joseph.larmarange.net/spip.php?id_mot=38&amp;page=backend" rel="self" type="application/rss+xml" />

	<image>
		<title>Joseph Larmarange</title>
		<url>https://www.joseph.larmarange.net/local/cache-vignettes/L144xH52/joseph_larmarange_site-6e82f.svg?1649686173</url>
		<link>https://joseph.larmarange.net/</link>
		<height>52</height>
		<width>144</width>
	</image>



<item xml:lang="fr">
		<title>&#171;&#160;L&#224;-bas est un peu loin&#160;&#187;&#160;: mobilit&#233;s saisonni&#232;res, observance des traitements et r&#233;gularit&#233; du suivi m&#233;dical dans une cohorte de travailleuses du sexe en C&#244;te d'Ivoire</title>
		<link>https://www.joseph.larmarange.net/la-bas-est-un-peu-loin-mobilites</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/la-bas-est-un-peu-loin-mobilites</guid>
		<dc:date>2024-09-02T17:36:06Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>R&#233;tention dans les soins</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Auteurs &lt;br class='autobr' /&gt;
Valentine Becquet, Hector Juliard, Joseph Larmarange &lt;br class='autobr' /&gt;
R&#233;sum&#233; &lt;br class='autobr' /&gt;
Contexte &lt;br class='autobr' /&gt;
Le projet Princesse a d&#233;velopp&#233;, document&#233; et analys&#233; une offre globale de sant&#233; sexuelle et reproductive incluant la pr&#233;vention combin&#233;e du VIH, aupr&#232;s d'une cohorte de travailleuses du sexe &#224; San Pedro en C&#244;te d'Ivoire. Cette offre de sant&#233;, mise en place entre novembre 2019 et juin 2023, impliquait un suivi m&#233;dical trimestriel, notamment en raison de la d&#233;livrance de la prophylaxie pr&#233;-exposition (PrEP),&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Retention-dans-les-soins-+" rel="tag"&gt;R&#233;tention dans les soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L112xH150/img-20210903-wa0039-19abd.jpg?1763097401' class='spip_logo spip_logo_right' width='112' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-4683551&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04683525v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04683525v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;&#171; L&#224;-bas est un peu loin &#187; : mobilit&#233;s saisonni&#232;res, observance des traitements et r&#233;gularit&#233; du suivi m&#233;dical dans une cohorte de travailleuses du sexe en C&#244;te d'Ivoire&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valentine-becquet&#034; class=&#034;hal-auteur&#034;&gt;Valentine Becquet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Hector+Juliard&#034; class=&#034;hal-auteur&#034;&gt;Hector Juliard&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;XXIIe Colloque de l'AIDELF&lt;/i&gt;, Association Internationale des D&#233;mographes de Langue Fran&#231;aise, Aug 2024, Aveiro, Portugal&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04683525v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04683525&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;h2 class=&#034;spip&#034;&gt;
Auteurs&lt;/h2&gt;
&lt;p&gt;Valentine Becquet, Hector Juliard, Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Contexte&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Le projet Princesse a d&#233;velopp&#233;, document&#233; et analys&#233; une offre globale de sant&#233; sexuelle et reproductive incluant la pr&#233;vention combin&#233;e du VIH, aupr&#232;s d'une cohorte de travailleuses du sexe &#224; San Pedro en C&#244;te d'Ivoire. Cette offre de sant&#233;, mise en place entre novembre 2019 et juin 2023, impliquait un suivi m&#233;dical trimestriel, notamment en raison de la d&#233;livrance de la prophylaxie pr&#233;-exposition (PrEP), m&#233;dicament qui prot&#232;ge du VIH lors de rapports sexuels sans pr&#233;servatif. Toutefois, une grande partie des femmes incluses dans cette cohorte ont connu des interruptions dans leur suivi m&#233;dical et donc dans leur traitement, &#224; plus ou moins long terme. D'une part, le suivi a &#233;t&#233; compliqu&#233; par le contexte de la r&#233;gion de San Pedro&#160;: r&#233;put&#233;e pour la culture du caf&#233; et du cacao, elle attire ainsi entre septembre et d&#233;cembre de nombreux travailleurs saisonniers dans les champs, mais &#233;galement des travailleuses du sexe. Une partie des femmes incluses dans cette p&#233;riode de l'ann&#233;e repartaient, &#224; la fin de la saison de r&#233;colte, dans leur r&#233;gion d'origine et nombreuses &#233;taient les perdues de vue, jusqu'&#224; l'ann&#233;e suivante ou d&#233;finitivement. D'autre part, dans les p&#233;riodes de l'ann&#233;e o&#249; l'activit&#233; diminue, de nombreuses femmes r&#233;sidant &#224; San Pedro voyagent plusieurs semaines pour visiter leur famille ou un client r&#233;gulier, dans d'autres r&#233;gions ivoiriennes ou dans leur pays d'origine (au Nigeria souvent, mais &#233;galement dans des pays francophones de la sous-r&#233;gion), interrompant alors leur prise de PrEP ou manquant leur rendez-vous trimestriel, ce qui complique le suivi m&#233;dical (d&#233;pistage et traitement des infections sexuellement transmissibles dont le VIH notamment).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Objectif&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;L'objectif de cette communication est d'&#233;tudier les mobilit&#233;s temporaires ou saisonni&#232;res des femmes incluses dans la cohorte Princesse, et les cons&#233;quences qu'elles ont sur l'observance de la PrEP, et plus largement sur leur suivi m&#233;dical.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Donn&#233;es et m&#233;thodes&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;L'ensemble de soins de sant&#233; sexuelle et reproductive du projet Princesse a &#233;t&#233; propos&#233; dans une clinique communautaire et via une clinique mobile op&#233;rant sur 10 sites de prostitution (visit&#233;s toutes les deux semaines) pendant 45 mois (d&#233;cembre 2019 &#8211; juin 2023). L'analyse repose sur des entretiens qualitatifs r&#233;alis&#233;s avec 38 travailleuses du sexe en d&#233;cembre 2019, septembre 2021, mars et mai 2022, ainsi que sur les questionnaires socio-comportementaux compl&#233;t&#233;s par les femmes tous les six mois au cours de leur suivi. Les trajectoires de mobilit&#233;, d&#233;crites pr&#233;cis&#233;ment dans ces questionnaires, seront mises en regard avec les trajectoires de PrEP (initiation, observance, interruption ou arr&#234;t d&#233;finitif) et les trajectoires de suivi m&#233;dical (r&#233;gularit&#233; du suivi, perte de vue), retrac&#233;es gr&#226;ce aux fiches cliniques remplies par l'&#233;quipe m&#233;dicale.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>SENOVIE</title>
		<link>https://www.joseph.larmarange.net/senovie</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/senovie</guid>
		<dc:date>2024-07-02T17:15:15Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>SENOVIE</dc:subject>
		<dc:subject>Cancer du sein</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>B&#233;nin</dc:subject>
		<dc:subject>Cambodge</dc:subject>
		<dc:subject>France</dc:subject>
		<dc:subject>Mali</dc:subject>

		<description>
&lt;p&gt;Responsable scientifique Cl&#233;mence Schantz &lt;br class='autobr' /&gt;
Partenaires &lt;br class='autobr' /&gt;
Liste compl&#232;te sur &lt;br class='autobr' /&gt;
France IRD Ined CHU Saint-Louis (Senop&#244;le), Paris H&#244;pital Delafontaine, Saint-Denis Inserm UPEC Universit&#233; Paris Nanterre &lt;br class='autobr' /&gt;
Mali Facult&#233; de M&#233;decine et d'Odontostomatologie de Bamako Association &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;Les Combattantes du Cancer&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;, Bamako INSP, Bamako Centre de Sant&#233; de R&#233;f&#233;rence de la Commune 2, Bamako H&#244;pital du Mali, Bamako &lt;br class='autobr' /&gt;
B&#233;nin CNHU, Cotonou Minist&#232;re de la sant&#233;, Cotonou CHU-MEL, Cotonou &lt;br class='autobr' /&gt;
Cambodge H&#244;pital&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Projets-de-Recherche-" rel="directory"&gt;Projets de Recherche&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-senovie-171-+" rel="tag"&gt;SENOVIE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-cancer-du-sein-+" rel="tag"&gt;Cancer du sein&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Benin-+" rel="tag"&gt;B&#233;nin&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cambodge-+" rel="tag"&gt;Cambodge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-France-+" rel="tag"&gt;France&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L100xH150/pexels-photo-6303780-4c58e.jpg?1719942153' class='spip_logo spip_logo_right' width='100' height='150' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;figure class='spip_document_601 spip_documents spip_documents_right media media_image media_image_jpg' style='float:right;'&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L390xH360/logo_senovie-2c0bc-3af61.jpg?1719942153' width='390' height='360' alt='JPEG - 1 Mio' /&gt;&lt;/figure&gt;&lt;h2 class=&#034;spip&#034;&gt;
Responsable scientifique&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Cl&#233;mence Schantz&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Partenaires&lt;/h2&gt;
&lt;p&gt;Liste compl&#232;te sur &lt;a href=&#034;https://www.ceped.org/senovie&#034; class=&#034;spip_url spip_out&#034; rel=&#034;external&#034;&gt;https://www.ceped.org/senovie&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;France&lt;/strong&gt;&lt;/p&gt;
&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; IRD&lt;/li&gt;&lt;li&gt; Ined&lt;/li&gt;&lt;li&gt; CHU Saint-Louis (Senop&#244;le), Paris&lt;/li&gt;&lt;li&gt; H&#244;pital Delafontaine, Saint-Denis&lt;/li&gt;&lt;li&gt; Inserm&lt;/li&gt;&lt;li&gt; UPEC&lt;/li&gt;&lt;li&gt; Universit&#233; Paris Nanterre&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Mali&lt;/strong&gt;&lt;/p&gt;
&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Facult&#233; de M&#233;decine et d'Odontostomatologie de Bamako&lt;/li&gt;&lt;li&gt; Association &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;Les Combattantes du Cancer&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;, Bamako&lt;/li&gt;&lt;li&gt; INSP, Bamako&lt;/li&gt;&lt;li&gt; Centre de Sant&#233; de R&#233;f&#233;rence de la Commune 2, Bamako&lt;/li&gt;&lt;li&gt; H&#244;pital du Mali, Bamako&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;B&#233;nin&lt;/strong&gt;&lt;/p&gt;
&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; CNHU, Cotonou&lt;/li&gt;&lt;li&gt; Minist&#232;re de la sant&#233;, Cotonou&lt;/li&gt;&lt;li&gt; CHU-MEL, Cotonou&lt;/li&gt;&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Cambodge&lt;/strong&gt;&lt;/p&gt;
&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; H&#244;pital Calmette, Phnom Penh&lt;/li&gt;&lt;li&gt; Douleurs sans fronti&#232;re&lt;/li&gt;&lt;li&gt; Universit&#233; des Beaux-Arts&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Financements&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;a href=&#034;https://institut-du-genre.fr/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;GIS Institut du Genre&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;https://citedugenre.fr/fr/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;la Cit&#233; du Genre&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;https://www.icmigrations.cnrs.fr/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Institut Convergences et Migrations&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;https://www.e-cancer.fr/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Institut National du Cancer (INCa)&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;https://www.msf.fr/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;M&#233;decins sans Fronti&#232;res (MSF)&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;https://kh.ambafrance.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Ambassade de France au Cambodge - MEAE&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233; &lt;/h2&gt;
&lt;p&gt;Le cancer du sein est le cancer le plus fr&#233;quent au monde. Dans de nombreux pays des Suds, les ressources th&#233;rapeutiques sont faibles, ce qui am&#232;ne certaines femmes en qu&#234;te de soins &#224; quitter leur pays. Avec une approche biographique mixte (&#224; la fois qualitative et quantitative), nous retra&#231;ons les parcours de vie de ces femmes et cherchons &#224; pr&#233;ciser ce qu'impliquent ces mobilit&#233;s th&#233;rapeutiques en termes de v&#233;cus et de ruptures biographiques. Afin d'avoir une vision globale de ces circulations, et afin de saisir les raisons qui am&#232;nent certaines femmes &#224; partir, nous menons cette recherche en France (r&#233;gion Ile de France) mais aussi en Afrique de l'Ouest (Mali, B&#233;nin) et Asie du Sud-Est (Cambodge). Avec le souci constant de co-contruire nos connaissances, et en impliquant des chercheur&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;es, des soignant&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;es et des associations de femmes, cette recherche souhaite contribuer &#224; la lutte contre les in&#233;galit&#233;s sociales de sant&#233; et &#224; la mise en lumi&#232;re de ces cancers en Afrique de l'Ouest et en Asie du Sud-Est.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Mots-Cl&#233;s &lt;/h2&gt;
&lt;p&gt;Migrations, Cancers, Genre, Afrique, Asie&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Zones g&#233;ographiques (terrains de recherche)&lt;/h2&gt;
&lt;p&gt;France, Mali, B&#233;nin, Cambodge&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Calendrier&lt;/h2&gt;
&lt;p&gt;2021-2026&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Derni&#232;res publications&lt;/h2&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-5332921&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05332921v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05332921v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;How a quantitative biographical approach can help in understanding the complex intersections of breast cancer, migration and gender ? The case of the SENOVIE France study&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731078343&#034; class=&#034;hal-auteur&#034;&gt;Luis Teixeira&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731261800&#034; class=&#034;hal-auteur&#034;&gt;Gaetan Des Guetz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=742673855676&#034; class=&#034;hal-auteur&#034;&gt;Laurent Zelek&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/anne-gosselin&#034; class=&#034;hal-auteur&#034;&gt;Anne Gosselin&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;SLLS Annual Conference 2025&lt;/i&gt;, Society for Longitudinal and Lifecourse Studies, Sep 2025, Fribourg (Suisse), Switzerland&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05332921v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05332921&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5332880&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05332880v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05332880v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;The contribution of a quantitative biographical approach in studying the social and health trajectories of immigrant and French-born women receiving breast cancer care in the greater Paris area&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/annabel-desgrees-du-lou&#034; class=&#034;hal-auteur&#034;&gt;Annabel Desgr&#233;es du Lo&#251;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/anne-gosselin&#034; class=&#034;hal-auteur&#034;&gt;Anne Gosselin&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;22nd IMISCOE Annual Conference&lt;/i&gt;, IMISCOE, Jul 2025, Auberviliers, Campus Condorcet, France&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05332880v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05332880&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5124533&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05124533v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05124533v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Global therapeutic mobilities and cancer: a scoping review&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/sarah-boisson&#034; class=&#034;hal-auteur&#034;&gt;Sarah Boisson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/leaprost-lancon&#034; class=&#034;hal-auteur&#034;&gt;L&#233;a Prost-Lan&#231;on&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Emmanuel+Bonnet&#034; class=&#034;hal-auteur&#034;&gt;Emmanuel Bonnet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aur%C3%A9lien+Dancoisne&#034; class=&#034;hal-auteur&#034;&gt;Aur&#233;lien Dancoisne&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/myriam-baron&#034; class=&#034;hal-auteur&#034;&gt;Myriam Baron&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/audrey-bochaton&#034; class=&#034;hal-auteur&#034;&gt;Audrey Bochaton&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;BMJ Open&lt;/i&gt;, 2025, 15 (6), pp.e089780. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1136/bmjopen-2024-089780&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1136/bmjopen-2024-089780&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05124533v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05124533&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5111610&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05111610v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L57xH75/thumb-895e538c-a545f.png?1750151393' alt=&#034;Image document&#034; width='57' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05111610v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Knowledge transfer interventions on cancer in Africa and Asia: a scoping review&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731551770&#034; class=&#034;hal-auteur&#034;&gt;Julie Robin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Madani+Ly&#034; class=&#034;hal-auteur&#034;&gt;Madani Ly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Bakary+Abou+Traore&#034; class=&#034;hal-auteur&#034;&gt;Bakary Abou Traore&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kadiatou+Faye&#034; class=&#034;hal-auteur&#034;&gt;Kadiatou Faye&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Aur%C3%A9lien+Dancoisne&#034; class=&#034;hal-auteur&#034;&gt;Aur&#233;lien Dancoisne&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/valery-ridde&#034; class=&#034;hal-auteur&#034;&gt;Val&#233;ry Ridde&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;BMC Cancer&lt;/i&gt;, 2025, 25 (1), pp.704. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1186/s12885-025-14061-8&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1186/s12885-025-14061-8&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05111610v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05111610&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-5024614&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-05019538v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L57xH75/thumb-42724ec5-02b79.png?1744112227' alt=&#034;Image document&#034; width='57' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05019538v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;A Life course approach to investigate breast cancer and migration in the greater Paris area: the SENOVIE study protocol&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Cl%C3%A9mence+Schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Luis+Teixeira&#034; class=&#034;hal-auteur&#034;&gt;Luis Teixeira&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/annabel-desgrees-du-lou&#034; class=&#034;hal-auteur&#034;&gt;Annabel Desgr&#233;es du Lo&#251;&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ga%C3%ABtan+Des+Guetz&#034; class=&#034;hal-auteur&#034;&gt;Ga&#235;tan Des Guetz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Hamid+Hocini&#034; class=&#034;hal-auteur&#034;&gt;Hamid Hocini&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Laurent+Zelek&#034; class=&#034;hal-auteur&#034;&gt;Laurent Zelek&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Anne+Gosselin&#034; class=&#034;hal-auteur&#034;&gt;Anne Gosselin&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;BMJ Open&lt;/i&gt;, 2025, 15 (4), pp.e095759. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1136/bmjopen-2024-095759&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1136/bmjopen-2024-095759&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-05019538v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-05019538&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-4639785&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04639785v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04639785v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;R&#233;fl&#233;chir sur les cancers du sein en interdisciplinarit&#233; et &#224; la lumi&#232;re des rapports sociaux de genre : retour r&#233;flexif sur le projet SENOVIE&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/sarah-boisson&#034; class=&#034;hal-auteur&#034;&gt;Sarah Boisson&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authIdPerson_i=7426731078343&#034; class=&#034;hal-auteur&#034;&gt;Luis Teixeira&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;XXIIe Congr&#232;s International des Sociologues de Langue Fran&#231;aise&lt;/i&gt;, AISLF, Jul 2024, Ottawa, Canada&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04639785v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04639785&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-4730706&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://sorbonne-paris-nord.hal.science/hal-04730706v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://sorbonne-paris-nord.hal.science/hal-04730706v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Associations de lutte contre les cancers du sein en &#206;le-de-France&#160;: quelles implications aupr&#232;s des femmes immigr&#233;es d'Afrique subsaharienne&#160;?&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Marie+Bottin&#034; class=&#034;hal-auteur&#034;&gt;Marie Bottin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=L%C3%A9a+Prost&#034; class=&#034;hal-auteur&#034;&gt;L&#233;a Prost&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Louise+Ludet&#034; class=&#034;hal-auteur&#034;&gt;Louise Ludet&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Ga%C3%ABtan+Des+Guetz&#034; class=&#034;hal-auteur&#034;&gt;Ga&#235;tan Des Guetz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Luis+Teixeira&#034; class=&#034;hal-auteur&#034;&gt;Luis Teixeira&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/myriam-baron&#034; class=&#034;hal-auteur&#034;&gt;Myriam Baron&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Groupe+Senovie&#034; class=&#034;hal-auteur&#034;&gt;Groupe Senovie&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Sant&#233; Publique&lt;/i&gt;, 2024, 36 (4), pp.47-59. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.3917/spub.244.0047&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.3917/spub.244.0047&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://sorbonne-paris-nord.hal.science/hal-04730706v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04730706&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-4612608&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04612608v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L75xH56/thumb-6846d337-4a53e.png?1743698659' alt=&#034;Image document&#034; width='75' height='56' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04612608v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;The challenge of radiotherapy in the fight against cancer in French-speaking West Africa&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;The social and political lives of new cancer technologies in the global South&lt;/i&gt;, Fondation Brocher, Jun 2024, Geneva, Switzerland&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-comm&#034;&gt;Communication dans un congr&#232;s&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04612608v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04612608&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-4593224&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://u-paris.hal.science/hal-04593224v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L57xH75/thumb-88ee19be-e759c.png?1760145749' alt=&#034;Image document&#034; width='57' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://u-paris.hal.science/hal-04593224v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Amazons in Mali? Women's experiences of breast cancer and gender (re)negotiation&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Abdourahmane+Coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Abdourahmane Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Kadiatou+Faye&#034; class=&#034;hal-auteur&#034;&gt;Kadiatou Faye&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/?q=*&amp;authFullName_s=Drissa+Traor%C3%A9&#034; class=&#034;hal-auteur&#034;&gt;Drissa Traor&#233;&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;&lt;i&gt;Social Science &amp; Medicine&lt;/i&gt;, 2024, 348, pp.116874. &lt;a target=&#034;_blank&#034; href=&#034;https://dx.doi.org/10.1016/j.socscimed.2024.116874&#034; rel=&#034;noreferrer noopener&#034;&gt;&#10216;10.1016/j.socscimed.2024.116874&#10217;&lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-art&#034;&gt;Article dans une revue&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://u-paris.hal.science/hal-04593224v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04593224&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-resultat hal-resultat-4563808&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://hal.science/hal-04563793v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-1df92121-96cff.png?1719942153' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04563793v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;Plan de gestion des donn&#233;es du projet SENOVIE France&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/anne-gosselin&#034; class=&#034;hal-auteur&#034;&gt;Anne Gosselin&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/karna-coulibaly&#034; class=&#034;hal-auteur&#034;&gt;Karna Coulibaly&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; , &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/clemence-schantz&#034; class=&#034;hal-auteur&#034;&gt;Cl&#233;mence Schantz&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;Institut de Recherche pour le D&#233;veloppement (IRD). 2024&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-report&#034;&gt;Rapport&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://hal.science/hal-04563793v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;hal-04563793&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&#034;hal-more hal-more-collection&#034;&gt;&lt;a href=&#034;https://hal.science/SENOVIE&#034;&gt;Voir la liste compl&#232;te des publications&lt;/a&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="fr">
		<title>D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne</title>
		<link>https://www.joseph.larmarange.net/hdr</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/hdr</guid>
		<dc:date>2022-10-14T06:38:12Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>ATLAS</dc:subject>
		<dc:subject>CAP-CoV-Soignants-BF</dc:subject>
		<dc:subject>DOD-CI (ANRS 12287 / 12323)</dc:subject>
		<dc:subject>ELIHoS (ANRS 12139)</dc:subject>
		<dc:subject>PrEP CI (ANRS 12361)</dc:subject>
		<dc:subject>Pr&#233;valences du VIH (ANRS 12114)</dc:subject>
		<dc:subject>prevR</dc:subject>
		<dc:subject>PRINCESSE</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Burkina Faso</dc:subject>
		<dc:subject>C&#244;te d'Ivoire</dc:subject>
		<dc:subject>Mali</dc:subject>
		<dc:subject>S&#233;n&#233;gal</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Analyse de s&#233;quences</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>
		<dc:subject>Approches communautaires</dc:subject>
		<dc:subject>Autotests VIH</dc:subject>
		<dc:subject>Cartographie</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Comparaison de cohortes</dc:subject>
		<dc:subject>Comportements sexuels</dc:subject>
		<dc:subject>D&#233;mographie</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)</dc:subject>
		<dc:subject>Enqu&#234;tes par t&#233;l&#233;phone</dc:subject>
		<dc:subject>Enseignement acad&#233;mique</dc:subject>
		<dc:subject>Lien vers les soins</dc:subject>
		<dc:subject>&#201;pid&#233;miologie</dc:subject>
		<dc:subject>Essais cliniques</dc:subject>
		<dc:subject>Estimateurs &#224; noyau (kernel density estimation)</dc:subject>
		<dc:subject>Femmes enceintes</dc:subject>
		<dc:subject>Financement des programmes</dc:subject>
		<dc:subject>H&#233;patites virales</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>
		<dc:subject>Identit&#233;s sexuelles</dc:subject>
		<dc:subject>Incidence du VIH</dc:subject>
		<dc:subject>Interpolation spatiale</dc:subject>
		<dc:subject>IST (Infections Sexuellement Transmissibles)</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Masculinit&#233;s</dc:subject>
		<dc:subject>M&#233;nages</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>M&#233;thodologie</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Observatoire de population</dc:subject>
		<dc:subject>Partenaires sexuel(le)s</dc:subject>
		<dc:subject>PrEP</dc:subject>
		<dc:subject>Pr&#233;valence du VIH</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Recherche interventionnelle</dc:subject>
		<dc:subject>Recherche participative/communautaire</dc:subject>
		<dc:subject>Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;</dc:subject>
		<dc:subject>Repr&#233;sentations / Perceptions</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>
		<dc:subject>Sant&#233; sexuelle</dc:subject>
		<dc:subject>Structure des populations</dc:subject>
		<dc:subject>Structures de sant&#233;</dc:subject>
		<dc:subject>Surveillance sentinelle</dc:subject>
		<dc:subject>T&#233;l&#233;phones mobiles</dc:subject>
		<dc:subject>Temporalit&#233;s</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Travail du sexe</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>
		<dc:subject>Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue</dc:subject>
		<dc:subject>VIH / SIDA</dc:subject>

		<description>
&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;. &lt;br class='autobr' /&gt; D&#233;crire les &#233;pid&#233;mies, Comprendre les populations&#160;: une d&#233;mographie du VIH en Afrique subsaharienne &lt;br class='autobr' /&gt; Joseph Larmarange D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022 HDR tel-03814024&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ATLAS-+" rel="tag"&gt;ATLAS&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-CAP-CoV-Soignants-BF-+" rel="tag"&gt;CAP-CoV-Soignants-BF&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-DOD-CI-ANRS-12287-+" rel="tag"&gt;DOD-CI (ANRS 12287 / 12323)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-ELIHoS-ANRS-12139-+" rel="tag"&gt;ELIHoS (ANRS 12139)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-CI-ANRS-12361-+" rel="tag"&gt;PrEP CI (ANRS 12361)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevalences-du-VIH-ANRS-12114-+" rel="tag"&gt;Pr&#233;valences du VIH (ANRS 12114)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-prevR-+" rel="tag"&gt;prevR&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PRINCESSE-+" rel="tag"&gt;PRINCESSE&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Burkina-Faso-+" rel="tag"&gt;Burkina Faso&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cote-d-Ivoire-+" rel="tag"&gt;C&#244;te d'Ivoire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mali-+" rel="tag"&gt;Mali&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Senegal-+" rel="tag"&gt;S&#233;n&#233;gal&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Analyse-de-sequences-+" rel="tag"&gt;Analyse de s&#233;quences&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-communautaires-+" rel="tag"&gt;Approches communautaires&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Autotests-VIH-+" rel="tag"&gt;Autotests VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cartographie-+" rel="tag"&gt;Cartographie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comparaison-de-cohortes-+" rel="tag"&gt;Comparaison de cohortes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Comportements-sexuels-+" rel="tag"&gt;Comportements sexuels&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Demographie-+" rel="tag"&gt;D&#233;mographie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-EDS-Enquetes-Demographiques-et-de-+" rel="tag"&gt;EDS (Enqu&#234;tes D&#233;mographiques et de Sant&#233;)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Enquetes-par-telephone-+" rel="tag"&gt;Enqu&#234;tes par t&#233;l&#233;phone&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Enseignement-academique-+" rel="tag"&gt;Enseignement acad&#233;mique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Entree-en-soins-+" rel="tag"&gt;Lien vers les soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Epidemiologie-+" rel="tag"&gt;&#201;pid&#233;miologie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Essais-cliniques-+" rel="tag"&gt;Essais cliniques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Estimateurs-a-noyau-kernel-density-+" rel="tag"&gt;Estimateurs &#224; noyau (kernel density estimation)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Femmes-enceintes-+" rel="tag"&gt;Femmes enceintes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Financement-des-programmes-+" rel="tag"&gt;Financement des programmes&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Hepatites-virales-+" rel="tag"&gt;H&#233;patites virales&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Identites-sexuelles-+" rel="tag"&gt;Identit&#233;s sexuelles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Incidence-du-VIH-+" rel="tag"&gt;Incidence du VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Interpolation-spatiale-+" rel="tag"&gt;Interpolation spatiale&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-IST-Infections-Sexuellement-+" rel="tag"&gt;IST (Infections Sexuellement Transmissibles)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Masculinites-+" rel="tag"&gt;Masculinit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Menages-+" rel="tag"&gt;M&#233;nages&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Methodologie-+" rel="tag"&gt;M&#233;thodologie&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Observatoire-de-population-+" rel="tag"&gt;Observatoire de population&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Partenaires-sexuel-le-s-+" rel="tag"&gt;Partenaires sexuel(le)s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-PrEP-+" rel="tag"&gt;PrEP&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevalence-du-VIH-+" rel="tag"&gt;Pr&#233;valence du VIH&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-interventionnelle-+" rel="tag"&gt;Recherche interventionnelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recherche-participative-+" rel="tag"&gt;Recherche participative/communautaire&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Recrutement-boules-de-neige-+" rel="tag"&gt;Recrutement &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;boules de neige&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representations-Perceptions-+" rel="tag"&gt;Repr&#233;sentations / Perceptions&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-sexuelle-+" rel="tag"&gt;Sant&#233; sexuelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Structure-des-populations-+" rel="tag"&gt;Structure des populations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Structures-de-sante-+" rel="tag"&gt;Structures de sant&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Surveillance-sentinelle-+" rel="tag"&gt;Surveillance sentinelle&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Telephones-mobiles-+" rel="tag"&gt;T&#233;l&#233;phones mobiles&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Temporalites-142-+" rel="tag"&gt;Temporalit&#233;s&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Travail-du-sexe-+" rel="tag"&gt;Travail du sexe&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Usagers-de-drogue-par-voie-+" rel="tag"&gt;Usager&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;e&lt;span aria-hidden='true'&gt;&#183;&lt;/span&gt;s de drogue&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH109/ruban_spirales-a3fec.png?1715097926' class='spip_logo spip_logo_right' width='150' height='109' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Habilitation &#224; Diriger des Recherches soutenue le 12&#160;octobre 2012 par Joseph Larmarange &#224; l'Universit&#233; Paris Cit&#233;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;div class=&#034;hal-resultats&#034;&gt; &lt;div class=&#034;hal-resultat hal-resultat-3814024&#034;&gt; &lt;div class=&#034;hal-thumb&#034;&gt;&lt;a href=&#034;https://theses.hal.science/tel-03814024v1/document&#034; class=&#034;hal-thumb-link&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L53xH75/thumb-877a2ad2-17cac.png?1702907846' alt=&#034;Image document&#034; width='53' height='75' /&gt; &lt;/a&gt;&lt;/div&gt; &lt;div class=&#034;hal-preview&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-titre&#034;&gt; &lt;h3 class=&#034;hal-titre-heading&#034;&gt;D&#233;crire les &#233;pid&#233;mies, Comprendre les populations : une d&#233;mographie du VIH en Afrique subsaharienne&lt;/h3&gt; &lt;/a&gt; &lt;div class=&#034;hal-auteurs&#034;&gt; &lt;a href=&#034;https://hal.science/search/index/q/*/authIdHal_s/joseph-larmarange&#034; class=&#034;hal-auteur&#034;&gt;Joseph Larmarange&lt;/a&gt; &lt;/div&gt; &lt;div class=&#034;hal-citation&#034;&gt;D&#233;mographie. Universit&#233; Paris Cit&#233;, 2022&lt;/div&gt; &lt;div class=&#034;hal-typedoc hal-typedoc-hdr&#034;&gt;HDR&lt;/div&gt; &lt;div class=&#034;hal-links&#034;&gt; &lt;a href=&#034;https://theses.hal.science/tel-03814024v1&#034; class=&#034;hal-link hal-link-hal&#034;&gt;tel-03814024&lt;/a&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;&lt;iframe width=&#034;100%&#034; height=&#034;500&#034; src=&#034;https://www.youtube.com/embed/me6rDSq0p0k&#034; title=&#034;YouTube video player&#034; frameborder=&#034;0&#034; allow=&#034;accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture&#034; allowfullscreen&gt;&lt;/iframe&gt;&lt;h2 class=&#034;spip&#034;&gt;
Jury&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; Didier Breton (Universit&#233; de Strasbourg, rapporteur)&lt;/li&gt;&lt;li&gt; Val&#233;rie Delauney (IRD, rapportrice)&lt;/li&gt;&lt;li&gt; Annabel Desgr&#233;es du Lo&#251; (IRD, garante)&lt;/li&gt;&lt;li&gt; G&#233;raldine Duth&#233; (Ined, rapportrice)&lt;/li&gt;&lt;li&gt; Didier Ekouevi (Inserm, Universit&#233; de Lom&#233;, examinateur)&lt;/li&gt;&lt;li&gt; V&#233;ronique Petit (Universit&#233; Paris Cit&#233;, pr&#233;sidente)&lt;/li&gt;&lt;/ul&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/hdr_larmarange_v2022-10-12.pdf" length="15224200" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>Homo/bisexualit&#233;s et migrations de l'Afrique subsaharienne &#224; la France&#160;: quelles &#233;mancipations&#160;?</title>
		<link>https://www.joseph.larmarange.net/Homo-bisexualites-et-migrations-de</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Homo-bisexualites-et-migrations-de</guid>
		<dc:date>2019-08-30T07:00:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>France</dc:subject>
		<dc:subject>Approches biographiques</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Homo / Bisexualit&#233;s</dc:subject>

		<description>
&lt;p&gt;Communication orale pr&#233;sent&#233;e le 30&#160;ao&#251;t 2019 &#224; Anger dans le cadre du 2&lt;sup class=&#034;typo_exposants&#034;&gt;e&lt;/sup&gt; congr&#232;s international de l'Institut du Genre sur le th&#232;me Genre et &#201;mancipation. &lt;br class='autobr' /&gt; Auteurs &lt;br class='autobr' /&gt;
Julie Pannetier, &#201;lise Marsicano, Joseph Larmarange, Christophe Broqua &lt;br class='autobr' /&gt;
R&#233;sum&#233; &lt;br class='autobr' /&gt;
Dans une majorit&#233; de pays d'Afrique subsaharienne, les pratiques homosexuelles sont socialement condamn&#233;es, voire ill&#233;gales. La migration vers un pays d'Europe peut constituer une opportunit&#233; de vivre diff&#233;remment son homo-bisexualit&#233;, et ce, que&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-France-+" rel="tag"&gt;France&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Approches-biographiques-+" rel="tag"&gt;Approches biographiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-MSM-Homo-Bisexualite-+" rel="tag"&gt;Homo / Bisexualit&#233;s&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH74/arton258-4b36f.jpg?1715174793' class='spip_logo spip_logo_right' width='150' height='74' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Communication orale pr&#233;sent&#233;e le 30&#160;ao&#251;t 2019 &#224; Anger dans le cadre du &lt;a href=&#034;https://congresgenre19.sciencesconf.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;2&lt;sup&gt;e&lt;/sup&gt; congr&#232;s international de l'Institut du Genre&lt;/a&gt; sur le th&#232;me &lt;i&gt;Genre et &#201;mancipation&lt;/i&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Auteurs&lt;/h2&gt;
&lt;p&gt;Julie Pannetier, &#201;lise Marsicano, Joseph Larmarange, Christophe Broqua&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;sum&#233;&lt;/h2&gt;
&lt;p&gt;Dans une majorit&#233; de pays d'Afrique subsaharienne, les pratiques homosexuelles sont socialement condamn&#233;es, voire ill&#233;gales. La migration vers un pays d'Europe peut constituer une opportunit&#233; de vivre diff&#233;remment son homo-bisexualit&#233;, et ce, que la question de l'homosexualit&#233; soit ou non le moteur de la migration. Les liens entre homo/bisexualit&#233;s et migrations ont jusqu'ici &#233;t&#233; peu explor&#233;s. Quelles sont les trajectoires des personnes migrantes ayant eu des relations homosexuelles au cours de leur vie&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? Comment les relations avec des partenaires de m&#234;me sexe s'inscrivent-elles dans les trajectoires relationnelles dans le pays d'origine et en contexte migratoire&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? Dans quelle mesure la migration influe-t-elle sur les relations affectives et sexuelles&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? Donne-t-elle acc&#232;s &#224; de meilleures conditions de vie et/ou de soins&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;? Nous souhaitons travailler ces questions &#224; partir de l'enqu&#234;te Parcours 2012-2013 qui porte sur les migrations subsahariennes en &#206;le-de-France et la sant&#233; de ces populations, notamment les pathologies VIH et l'h&#233;patite B. Dans cette enqu&#234;te biographique, les parcours migratoire, r&#233;sidentiel, juridique, &#233;conomique, les relations affectives et sexuelles et les trajectoires de sant&#233; ont &#233;t&#233; collect&#233;s tout au long de la vie. Cela permet de reconstruire sous la forme d'un &#171;&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;r&#233;cit de vie&lt;small class=&#034;fine d-inline&#034;&gt;&#160;&lt;/small&gt;&#187;, le cheminement des personnes ayant d&#233;clar&#233; au moins un partenaire de m&#234;me sexe au cours de leur vie, soit 12 femmes et 23 hommes et de d&#233;crire leurs trajectoires, dans leurs diversit&#233;s.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
R&#233;f&#233;rence&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;6IZTQ3U6&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Pannetier&lt;/span&gt; Julie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Marsicano&lt;/span&gt; &#201;lise, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Broqua&lt;/span&gt; Christophe (2019) &#171;&#160;Homo/bisexualit&#233;s et migrations de l'Afrique subsaharienne &#224; la France : quelles &#233;mancipations ?&#160;&#187; (communication orale), pr&#233;sent&#233; &#224; &lt;span style=&#034;font-style: italic;&#034; &gt;2e congr&#232;s international de l'Institut du Genre&lt;/span&gt;, Anger. https://congresgenre19.sciencesconf.org/.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>Mobility in Africa: human rights and the HIV care cascade</title>
		<link>https://www.joseph.larmarange.net/Mobility-in-Africa-human-rights</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Mobility-in-Africa-human-rights</guid>
		<dc:date>2018-07-30T09:37:10Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Pr&#233;vention</dc:subject>
		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Droits humains</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Europe</dc:subject>

		<description>
&lt;p&gt;Oral communication presented at the 22&lt;sup class=&#034;typo_exposants&#034;&gt;nd&lt;/sup&gt; International AIDS Conference in Amsterdam the 24&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; of July, 2018, in a satellite session entitled Population Mobility: Challenges for Universal HIV Testing and Treatment. Author &lt;br class='autobr' /&gt;
Joseph Larmarange See also &lt;br class='autobr' /&gt;
The impact of population dynamics on the population HIV care cascade&#160;: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu&#8208;Natal (South Africa) Medias aidsmap Reference &lt;br class='autobr' /&gt;
Larmarange Joseph (2018) &#171;&#160;Mobility in Africa:&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prevention-+" rel="tag"&gt;Pr&#233;vention&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Droits-humains-+" rel="tag"&gt;Droits humains&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Europe-+" rel="tag"&gt;Europe&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH100/arton237-c6e7d.jpg?1715148446' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Oral communication presented at the &lt;a href=&#034;http://www.aids2018.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;22&lt;sup&gt;nd&lt;/sup&gt; International AIDS Conference&lt;/a&gt; in Amsterdam the 24&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; of July, 2018, in a satellite session entitled &lt;i&gt;Population Mobility: Challenges for Universal HIV Testing and Treatment&lt;/i&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Author&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
See also&lt;/h2&gt;
&lt;p&gt;&lt;a href='https://www.joseph.larmarange.net/The-impact-of-population-dynamics' class=&#034;spip_in&#034; hreflang=&#034;fr&#034;&gt;The impact of population dynamics on the population HIV care cascade&#160;: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu&#8208;Natal (South Africa)&lt;/a&gt;&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Medias&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;a href=&#034;http://www.aidsmap.com/page/3313860/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;aidsmap&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;4GK2B3MK&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph (2018) &#171;&#160;Mobility in Africa: human rights and the HIV care cascade&#160;&#187; (communication orale TUSA1802), pr&#233;sent&#233; &#224; &lt;span style=&#034;font-style: italic;&#034; &gt;22nd International AIDS Conference&lt;/span&gt;, Amsterdam. http://programme.aids2018.org/Programme/Session/221.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/aids_2018_ssuttn_symposium_larmarange.pdf" length="2863191" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>The impact of population dynamics on the population HIV care cascade&#160;: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu&#8208;Natal (South Africa)</title>
		<link>https://www.joseph.larmarange.net/The-impact-of-population-dynamics</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/The-impact-of-population-dynamics</guid>
		<dc:date>2018-07-20T06:54:03Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Mesure des indicateurs</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Structure des populations</dc:subject>
		<dc:subject>Repr&#233;sentativit&#233; et Biais</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>

		<description>
&lt;p&gt;Authors &lt;br class='autobr' /&gt;
Joseph Larmarange, Mamadou Hassimiou Diallo, Nuala McGrath, Collins Iwuji, M&#233;lanie Plazy, Rodolphe Thi&#233;baut, Frank Tanser, Till B&#228;rnighausen, Deenan Pillay, Fran&#231;ois Dabis, Joanna Orne&#8208;Gliemann for the ANRS 12249 TasP Study Group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Introduction &lt;br class='autobr' /&gt;
The universal test and treat strategy (UTT) was developed to maximize the proportion of all HIV&#8208;positive individuals on antiretroviral treatment (ART) and virally suppressed, assuming that it will lead to a reduction in HIV&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Publications-11-" rel="directory"&gt;Publications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Validite-de-la-mesure-+" rel="tag"&gt;Mesure des indicateurs&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Structure-des-populations-+" rel="tag"&gt;Structure des populations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Representativite-et-Biais-+" rel="tag"&gt;Repr&#233;sentativit&#233; et Biais&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH112/arton236-1ee78.png?1715161566' class='spip_logo spip_logo_right' width='150' height='112' alt=&#034;&#034; /&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, Mamadou Hassimiou Diallo, Nuala McGrath, Collins Iwuji, M&#233;lanie Plazy, Rodolphe Thi&#233;baut, Frank Tanser, Till B&#228;rnighausen, Deenan Pillay, Fran&#231;ois Dabis, Joanna Orne&#8208;Gliemann for the ANRS 12249 TasP Study Group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The universal test and treat strategy (UTT) was developed to maximize the proportion of all HIV&#8208;positive individuals on antiretroviral treatment (ART) and virally suppressed, assuming that it will lead to a reduction in HIV incidence at the population level. The evolution over time of the cross&#8208;sectional HIV care cascade is determined by individual longitudinal trajectories through the HIV care continuum and underlying population dynamics. The purpose of this paper is to quantify the contribution of each component of population change (in&#8208; and out&#8208;migration, HIV seroconversion, ageing into the cohort and definitive exit such as death) on the HIV care cascade in the context of the ANRS 12249 Treatment as Prevention (TasP) cluster&#8208;randomized trial, investigating UTT in rural KwaZulu&#8208;Natal, South Africa, between 2012 and 2016.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;HIV test results and information on clinic visits, ART prescriptions, viral load and CD4 count, migration and deaths were used to calculate residency status, HIV status and HIV care status for each individual on a daily basis. Position within the HIV care continuum was considered as a score ranging from 0 (undiagnosed) to 4 (virally suppressed). We compared the cascade score of each individual joining or leaving the population of resident adults living with HIV with the average score of their cluster at the time of entry or exit. Then, we computed the contribution of each entry or exit on the average cascade score and their annualized total contribution, by component of change.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;While the average cascade score increased over time in all clusters, that increase was constrained by population dynamics. Permanent exits and ageing into the people living with HIV cohort had a marginal effect. Both in&#8208;migrants and out&#8208;migrants were less likely to be retained at each step of the HIV care continuum. However, their overall impact on the cross&#8208;sectional cascade was limited as the effect of in&#8208; and out&#8208;migration balanced each other. The contribution of HIV seroconversions was negative in all clusters.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;In a context of high HIV incidence, the continuous flow of newly infected individuals slows down the efforts to increase ART coverage and population viral suppression, ultimately attenuating any population&#8208;level impact on HIV incidence.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Clinical Trial Number&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;NCT01509508 (clinicalTrials.gov)/DOH&#8208;27&#8208;0512&#8208;3974 (South African National Clinical Trials Register).&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;DQRJ52CL&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Diallo&lt;/span&gt; Mamadou Hassimiou, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;McGrath&lt;/span&gt; Nuala, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Iwuji&lt;/span&gt; Collins, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Thi&#233;baut&lt;/span&gt; Rodolphe, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Tanser&lt;/span&gt; Frank, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;B&#228;rnighausen&lt;/span&gt; Till, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Pillay&lt;/span&gt; Deenan, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Dabis&lt;/span&gt; Fran&#231;ois et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Orne-Gliemann&lt;/span&gt; Joanna (2018) &#171;&#160;The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu-Natal (South Africa)&#160;&#187;, &lt;span style=&#034;font-style: italic;&#034; &gt;Journal of the International AIDS Society&lt;/span&gt;, 21 (S4) (juillet 20), p.&#160;e25128. DOI&#160;: 10.1002/jia2.25128. https://onlinelibrary.wiley.com/doi/abs/10.1002/jia2.25128.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		

	</item>
<item xml:lang="en">
		<title>From individual care trajectories to HIV care cascade at population level in rural KwaZulu-Natal (South Africa): the impact of population dynamics</title>
		<link>https://www.joseph.larmarange.net/from-individual-care-trajectories</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/from-individual-care-trajectories</guid>
		<dc:date>2018-06-06T14:57:15Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Milieu rural</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Lien vers les soins</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>
		<dc:subject>Universal Test &amp; Treat (UTT)</dc:subject>
		<dc:subject>Sant&#233; publique</dc:subject>

		<description>
&lt;p&gt;Oral communication presented May 31 2018 at Life History Research Society Conference in Paris. &lt;br class='autobr' /&gt; Authors &lt;br class='autobr' /&gt;
Joseph Larmarange, Mamadou Hassimiou Diallo, Nuala McGrath, Collins Iwuji, Rodolphe Thi&#233;baut, Frank Tanser, Till B&#228;rninghausen, Deenan Pillay, Fran&#231;ois Dabis, Joanna Orne-Gliemann for the ANRS 12249 TasP Study Group &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Introduction &lt;br class='autobr' /&gt;
The universal test-and-treat strategy (UTT) was developed to maximize the proportion of all HIV-positive individuals on antiretroviral and&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Milieu-rural-+" rel="tag"&gt;Milieu rural&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Entree-en-soins-+" rel="tag"&gt;Lien vers les soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Universal-Test-Treat-UTT-+" rel="tag"&gt;Universal Test &amp; Treat (UTT)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Sante-publique-+" rel="tag"&gt;Sant&#233; publique&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH100/arton232-06571.jpg?1715146380' class='spip_logo spip_logo_right' width='150' height='100' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Oral communication presented May 31 2018 at &lt;a href=&#034;http://lhrs2018paris.com/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Life History Research Society Conference&lt;/a&gt; in Paris.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, Mamadou Hassimiou Diallo, Nuala McGrath, Collins Iwuji, Rodolphe Thi&#233;baut, Frank Tanser, Till B&#228;rninghausen, Deenan Pillay, Fran&#231;ois Dabis, Joanna Orne-Gliemann for the ANRS 12249 TasP Study Group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Introduction&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The universal test-and-treat strategy (UTT) was developed to maximize the proportion of all HIV-positive individuals on antiretroviral and virally suppressed, assuming that it leads to reduction in HIV incidence. The evolution over time of the cross-sectional population HIV care cascade is determined by longitudinal individual trajectories through the HIV care continuum and the underlying HIV population dynamics. This structural effect could dilute the impact observed at population level of a UTT strategy RT: either add impact on what (incidence) or delete sentence. The purpose of this paper is to quantify the contribution of each component of population change on the population HIV care cascade in the context of UTT.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Sample&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;We used prospective individual-level longitudinal data from the ANRS 12249 cluster-randomized trial which was implemented in rural KwaZulu-Natal, South Africa between 2012 and 2016 to test such an approach.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;HIV tests results and information on clinic visits, ART prescription, viral load and CD4 count, migration and deaths were used to calculate residency status, HIV status and HIV care status for each individual on a daily basis. Position within the HIV care continuum was considered as a score ranging from 0 (undiagnosed) to 4 (virally suppressed). We compared the cascade score of each individual joining or leaving the HIV population with the average score of their cluster at the time of entry or exit. Then, we computed the contribution of each event on the average cascade score and the annualised total contribution of all events, considering 5 components of HIV population change: aging into the cohort, HIV seroconversions, in-migrations, out-migrations, and permanent exits (including deaths).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;While the average cascade score increased over time in all clusters, that increase was limited due to population dynamics, the total contribution of all population entries and exits being negative. Permanent exits and individuals already infected when reaching the age of 16 had a marginal effect. Although migrants had a lower position than the rest of the population, their overall impact on the cross-sectional population cascade remained limited as in- and out-migration compensated each other.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;In a context of high HIV incidence, the continuous flow of newly infected individuals slows down the efforts to increase ART coverage and population viral suppression.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;NCUMHKHF&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Diallo&lt;/span&gt; Mamadou Hassimiou, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;McGrath&lt;/span&gt; Nuala, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Iwuji&lt;/span&gt; Collins, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Thi&#233;baut&lt;/span&gt; Rodolphe, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Tanser&lt;/span&gt; Frank, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;B&#228;rnighausen&lt;/span&gt; Till, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Pillay&lt;/span&gt; Deenan, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Dabis&lt;/span&gt; Fran&#231;ois, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Orne-Gliemann&lt;/span&gt; Joanna et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;ANRS 12249 TasP Study Group&lt;/span&gt; (2018) &#171;&#160;From inspanidual care trajectories to HIV care cascade at population level in rural KwaZulu-Natal (South Africa): the impact of population dynamics&#160;&#187; (communication orale), pr&#233;sent&#233; &#224; &lt;span style=&#034;font-style: italic;&#034; &gt;Life History Research Society Conference&lt;/span&gt;, Paris.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/lhrs_tasp_v2018-05-31.pdf" length="2629987" type="application/pdf" />
		

	</item>
<item xml:lang="en">
		<title>Measuring the Impact of Test and Treat on the HIV Cascade: the Challenge of Mobility</title>
		<link>https://www.joseph.larmarange.net/Measuring-the-Impact-of-Test-and</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Measuring-the-Impact-of-Test-and</guid>
		<dc:date>2016-03-06T12:55:52Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>en</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>VIH / SIDA</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Milieu rural</dc:subject>
		<dc:subject>Afrique du Sud</dc:subject>
		<dc:subject>Mesure d'impact</dc:subject>
		<dc:subject>TasP (ANRS 12249)</dc:subject>
		<dc:subject>Traitement antir&#233;troviral (ARV)</dc:subject>
		<dc:subject>D&#233;pistage</dc:subject>
		<dc:subject>Prise en charge</dc:subject>
		<dc:subject>Treatment as Prevention (TasP)</dc:subject>
		<dc:subject>Cascade des soins</dc:subject>

		<description>
&lt;p&gt;Oral communication presented at CROI 2016 the 25&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; of February, 2016 in Boston. &lt;br class='autobr' /&gt; Authors &lt;br class='autobr' /&gt;
Joseph Larmarange, Collins Iwuji, Joanna Orne-Gliemann, Nuala McGrath, M&#233;lanie Plazy, Kathy Baisley, Till Barnigh&#228;usen, Fran&#231;ois Dabis, Deenan Pillay for the ANRS 12249 TasP Study Group &lt;br class='autobr' /&gt;
Ressources Webcast R&#233;sum&#233; par l'ANRS Interview pour la lettre de l'infectiologue Slides and text &lt;br class='autobr' /&gt;
Abstract &lt;br class='autobr' /&gt;
Background &lt;br class='autobr' /&gt;
Universal test and treat (UTT) could substantially improve the HIV care cascade at&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-VIH-SIDA-+" rel="tag"&gt;VIH / SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Milieu-rural-+" rel="tag"&gt;Milieu rural&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-du-Sud-+" rel="tag"&gt;Afrique du Sud&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mesure-d-impact-+" rel="tag"&gt;Mesure d'impact&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-TasP-ANRS-12249-97-+" rel="tag"&gt;TasP (ANRS 12249)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Traitement-antiretroviral-ARV-98-98-+" rel="tag"&gt;Traitement antir&#233;troviral (ARV)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Depistage-+" rel="tag"&gt;D&#233;pistage&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Prise-en-charge-+" rel="tag"&gt;Prise en charge&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Treatment-as-Prevention-TasP-105-+" rel="tag"&gt;Treatment as Prevention (TasP)&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Cascade-des-soins-+" rel="tag"&gt;Cascade des soins&lt;/a&gt;

		</description>


 <content:encoded>&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L150xH79/arton181-492bd.jpg?1715168157' class='spip_logo spip_logo_right' width='150' height='79' alt=&#034;&#034; /&gt;
		&lt;div class='rss_chapo'&gt;&lt;p&gt;Oral communication presented at &lt;a href=&#034;http://www.croiconference.org/&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;CROI 2016&lt;/a&gt; the 25&lt;sup class=&#034;typo_exposants&#034;&gt;th&lt;/sup&gt; of February, 2016 in Boston.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;h2 class=&#034;spip&#034;&gt;
Authors&lt;/h2&gt;
&lt;p&gt;Joseph Larmarange, Collins Iwuji, Joanna Orne-Gliemann, Nuala McGrath, M&#233;lanie Plazy, Kathy Baisley, Till Barnigh&#228;usen, Fran&#231;ois Dabis, Deenan Pillay for the ANRS 12249 TasP Study Group&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Ressources&lt;/h2&gt;&lt;ul class=&#034;spip&#034; role=&#034;list&#034;&gt;&lt;li&gt; &lt;a href=&#034;http://www.croiwebcasts.org/console/player/29736&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Webcast&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;http://www.anrs.fr/VIH-SIDA/Pays-a-ressources-limitees/Actualites/CROI-2016-Cascade-des-soins-en-Afrique-du-Sud-le-defi-de-la-mobilite&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;R&#233;sum&#233; par l'ANRS&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href=&#034;http://evenement.edimark.fr/ejournaux/CROI/2016/interview/7593/le-test-and-treat-en-marche-en-afrique-du-sud&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Interview pour la lettre de l'infectiologue&lt;/a&gt;&lt;/li&gt;&lt;li&gt; &lt;a href='https://www.joseph.larmarange.net/IMG/pdf/tasp_croi2016_v2016-02-24_text.pdf' class=&#034;spip_in&#034; type='application/pdf'&gt;Slides and text&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2 class=&#034;spip&#034;&gt;
Abstract&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Universal test and treat (UTT) could substantially improve the HIV care cascade at population level (i.e. the proportion of all HIV-infected people being diagnosed, on ART and virally suppressed at a given date) and thus reduce HIV incidence. Several trials are currently exploring this hypothesis.&lt;/p&gt;
&lt;p&gt;Due to demographic change, the study population of HIV-infected individuals is composed of people with various degrees of exposure to the trial interventions. This structural effect could potentially dilute the impact observed at population level of a UTT strategy. Here, we describe a dynamic cascade according to both calendar (population) and exposure (individual) time approaches, using preliminary data from the ANRS 12249 TasP cluster-randomized trial ongoing in rural KwaZulu-Natal (South Africa).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Analysis was conducted within a subgroup of 4 clusters with the longest follow-up time where five six-monthly rounds of home-based HIV testing had been conducted between March 2012 and July 2015. Resident members 16 years and above were offered rapid HIV testing and asked to provide dried blood spots (DBS) each time. Those ascertained HIV-positive were referred to local trial clinics for ART initiation and follow-up.&lt;/p&gt;
&lt;p&gt;HIV tests results and information on clinic visits, ART prescription, viral load and CD4 count, migration and death were used to calculate residency status, HIV status and HIV care status for each individual on each calendar day. This calendar cascade was then compared to the exposure cascade, where each status was recalculated for individuals at any given date with exposure time defined as the duration since trial registration.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/p&gt;
&lt;figure class='spip_document_223 spip_documents spip_documents_center media media_image media_image_png'&gt;&lt;a href='https://www.joseph.larmarange.net/IMG/png/croi_abstract.png' class=&#034;spip_in&#034; title=&#034;Figure 1 - CROI Abstract&#034; hreflang=&#034;&#034; type=&#034;image/png&#034;&gt;&lt;img src='https://www.joseph.larmarange.net/local/cache-vignettes/L240xH360/croi_abstract-6fccb-671a4.png?1643663847' width='240' height='360' alt='Figure 1 - CROI Abstract' /&gt;&lt;/a&gt;&lt;/figure&gt;
&lt;p&gt;According to calendar time, the overall cascade improved rapidly during the first 15 months of the trial (from 25 to 40% virally suppressed), but more slowly thereafter (Fig a). Although the target population size of HIV-infected people remained rather stable over time (&#160;665 individuals, Fig b), population turnover was high (Fig c). According to exposure time, with a decreasing sample size over time (Fig e), the cascade improved continuously between M0 and M30, from&#160;20% to&#160;50% virally suppressed (Fig. d).&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Population mobility dilutes the observed impact of UTT interventions on the cascade at population level. These preliminary findings also suggest that the impact of a UTT approach could be maximized as long as there is a coordination to facilitate continued access to care when people move.&lt;/p&gt;
&lt;h2 class=&#034;spip&#034;&gt;
Reference&lt;/h2&gt;
&lt;p&gt;&lt;abbr class=&#034;unapi-id&#034; title=&#034;4SZ7CJ93&#034;&gt;&lt;/abbr&gt;&lt;span class=&#034;csl-bib-body&#034;&gt;&lt;span class=&#034;csl-entry&#034;&gt;&lt;span style=&#034;font-variant: small-caps;&#034;&gt;Larmarange&lt;/span&gt; Joseph, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Iwuji&lt;/span&gt; Collins, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Orne-Gliemann&lt;/span&gt; Joanna, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;McGrath&lt;/span&gt; Nuala, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Plazy&lt;/span&gt; M&#233;lanie, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Baisley&lt;/span&gt; Kathy, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;B&#228;rnighausen&lt;/span&gt; Till, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Dabis&lt;/span&gt; Fran&#231;ois, &lt;span style=&#034;font-variant: small-caps;&#034;&gt;Pillay&lt;/span&gt; Deenan et &lt;span style=&#034;font-variant: small-caps;&#034;&gt;ANRS 12249 TasP Study Group&lt;/span&gt; (2016) &#171;&#160;Measuring the Impact of Test and Treat on the HIV Cascade: the Challenge of Mobility&#160;&#187; (communication orale), pr&#233;sent&#233; &#224; &lt;span style=&#034;font-style: italic;&#034; &gt;Conference on Retroviruses and Opportunistic Infections (CROI)&lt;/span&gt;, Boston. http://www.croiwebcasts.org/console/player/29736.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/tasp_croi2016_v2016-02-24_text.pdf" length="1759150" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>TD de D&#233;mographie - 2005</title>
		<link>https://www.joseph.larmarange.net/TD-de-Demographie-2005</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/TD-de-Demographie-2005</guid>
		<dc:date>2005-01-31T23:37:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Mortalit&#233;</dc:subject>
		<dc:subject>Mortalit&#233; infanto-juv&#233;nile</dc:subject>
		<dc:subject>F&#233;condit&#233;</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Structure des populations</dc:subject>
		<dc:subject>D&#233;mographie</dc:subject>

		<description>
&lt;p&gt;Ces TD s'ins&#232;rent dans le cadre de la premi&#232;re ann&#233;e de la licence Arts, Sciences Humaines et Sociales mention Sociologie de l'universit&#233; Fran&#231;ois Rabelais de Tours. &lt;br class='autobr' /&gt;
Deux enseignants interviennent en travaux dirig&#233;s&#160;: Joseph LARMARANGE, doctorant en d&#233;mographie, charg&#233; de cours &#224; l'universit&#233; F. Rabelais. Courriel&#160;: Laurent NOWIK, Ma&#238;tre de conf&#233;rences &#224; l'universit&#233; F. Rabelais. Courriel&#160;: &lt;br class='autobr' /&gt;
Les exercices r&#233;alis&#233;s en TD sont les m&#234;mes dans les six groupes. Avec autorisation de&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Enseignements-" rel="directory"&gt;Enseignements&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Mortalite-+" rel="tag"&gt;Mortalit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mortalite-infanto-juvenile-+" rel="tag"&gt;Mortalit&#233; infanto-juv&#233;nile&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Fecondite-+" rel="tag"&gt;F&#233;condit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Structure-des-populations-+" rel="tag"&gt;Structure des populations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Demographie-+" rel="tag"&gt;D&#233;mographie&lt;/a&gt;

		</description>


 <content:encoded>&lt;div class='rss_texte'&gt;&lt;p&gt;Ces TD s'ins&#232;rent dans le cadre de la premi&#232;re ann&#233;e de la licence &lt;i&gt;Arts, Sciences Humaines et Sociales&lt;/i&gt; mention &lt;i&gt;Sociologie&lt;/i&gt; de l'universit&#233; Fran&#231;ois Rabelais de Tours.&lt;/p&gt;
&lt;p&gt;Deux enseignants interviennent en travaux dirig&#233;s&#160;:&lt;/p&gt;
&lt;p&gt;&lt;span class=&#034;spip-puce ltr&#034;&gt;&lt;b&gt;&#8211;&lt;/b&gt;&lt;/span&gt; Joseph LARMARANGE, doctorant en d&#233;mographie, charg&#233; de cours &#224; l'universit&#233; F. Rabelais.&lt;br class='manualbr' /&gt;Courriel&#160;: &lt;a href=&#034;mailto:joseph.larmarange@paris5.sorbonne.fr&#034; class=&#034;spip_mail&#034;&gt;joseph.larmarange@paris5.sorbonne.fr&lt;/a&gt; &lt;br /&gt;&lt;span class=&#034;spip-puce ltr&#034;&gt;&lt;b&gt;&#8211;&lt;/b&gt;&lt;/span&gt; Laurent NOWIK, Ma&#238;tre de conf&#233;rences &#224; l'universit&#233; F. Rabelais.&lt;br class='manualbr' /&gt;Courriel&#160;: &lt;a href=&#034;mailto:laurent.nowik@univ-tours.fr&#034; class=&#034;spip_mail&#034;&gt;laurent.nowik@univ-tours.fr&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;Les exercices r&#233;alis&#233;s en TD sont les m&#234;mes dans les six groupes. Avec autorisation de l'enseignant, vous pouvez exceptionnellement int&#233;grer un autre TD si vous avez &#233;t&#233; absent. Les autres changements de groupe sont soumis &#224; demande aupr&#232;s de la Directrice des &#233;tudes de premi&#232;re ann&#233;e du D&#233;partement de sociologie.&lt;br&gt;
Les exercices seront mis en ligne &#224; mesure qu'ils auront &#233;t&#233; vus en TD. Ils ne se substituent donc pas &#224; une pr&#233;sence aux TD qui reste obligatoire.&lt;br&gt;
(La lecture des fichiers n&#233;cessite &lt;a href=&#034;http://www.adobe.fr&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;Acrobat Reader&lt;/a&gt;.)&lt;/p&gt;
&lt;p&gt;Vous pouvez consulter la bibliographie du cours de M.&#160;Nowik sur le site de l'universit&#233; de Tours &#224; cette adresse&#160;:&lt;br&gt;
&lt;a href=&#034;http://www.univ-tours.fr/ash/polycop/socio/nowik/demobib.htm&#034; class=&#034;spip_url spip_out&#034; rel=&#034;external&#034;&gt;http://www.univ-tours.fr/ash/polyco...&lt;/a&gt;.&lt;br&gt;
Nous vous invitons &#233;galement &#224; consulter le site web de M.&#160;Nowik&#160;:&lt;br&gt;
&lt;a href=&#034;http://perso.wanadoo.fr/laurent.nowik/&#034; class=&#034;spip_url spip_out&#034; rel=&#034;external&#034;&gt;http://perso.wanadoo.fr/laurent.nowik/&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Cette ann&#233;e la ville de Tours accueillera en juillet le &lt;a href=&#034;http://www.iussp.org/France2005/indexfr.php&#034; class=&#034;spip_out&#034; rel=&#034;external&#034;&gt;XXV&lt;sup&gt;e&lt;/sup&gt; congr&#232;s international sur la population&lt;/a&gt; qui se tient tous les quatre ans.&lt;/p&gt;
&lt;p&gt;Enfin, vous trouverez des annales des examens ainsi que des exercices corrig&#233;s sur &lt;a href='https://www.joseph.larmarange.net/TD-de-Demographie-2003-2004' class=&#034;spip_in&#034;&gt;cette page&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;
		&lt;hr /&gt;
		&lt;div &lt;div class='rss_ps'&gt;&lt;p&gt;60 heures de cours ont &#233;t&#233; effectu&#233;es en 2005.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_td1.pdf" length="419761" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_td2.pdf" length="497789" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_td3.pdf" length="1769842" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_td4_5.pdf" length="1051952" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_corriges_TD1-3.pdf" length="439501" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_TD3_commentaire_zones_d_emplois.pdf" length="56061" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_td6.pdf" length="540108" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/lexis_vide.pdf" length="2122" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_td7.pdf" length="305533" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/2005_betisier.pdf" length="97658" type="application/pdf" />
		

	</item>
<item xml:lang="fr">
		<title>Enqu&#234;te Population, Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime 2003</title>
		<link>https://www.joseph.larmarange.net/Enquete-Population-Pauvrete</link>
		<guid isPermaLink="true">https://www.joseph.larmarange.net/Enquete-Population-Pauvrete</guid>
		<dc:date>2003-11-03T00:36:00Z</dc:date>
		<dc:format>text/html</dc:format>
		<dc:language>fr</dc:language>
		<dc:creator>Joseph LARMARANGE</dc:creator>


		<dc:subject>Connaissance du VIH/SIDA</dc:subject>
		<dc:subject>Afrique subsaharienne</dc:subject>
		<dc:subject>Guin&#233;e</dc:subject>
		<dc:subject>Mortalit&#233;</dc:subject>
		<dc:subject>Population, Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime</dc:subject>
		<dc:subject>Pauvret&#233;</dc:subject>
		<dc:subject>Mortalit&#233; infanto-juv&#233;nile</dc:subject>
		<dc:subject>Itin&#233;raires th&#233;rapeutiques</dc:subject>
		<dc:subject>Monographies de village</dc:subject>
		<dc:subject>Ressources &#233;conomiques</dc:subject>
		<dc:subject>Activit&#233;s &#233;conomiques</dc:subject>
		<dc:subject>F&#233;condit&#233;</dc:subject>
		<dc:subject>Migrations</dc:subject>
		<dc:subject>Scolarisation</dc:subject>
		<dc:subject>Nuptialit&#233;</dc:subject>
		<dc:subject>Acc&#232;s aux soins</dc:subject>
		<dc:subject>Milieu rural</dc:subject>

		<description>
&lt;p&gt;Cette pr&#233;sentation s'inscrit dans les s&#233;minaires communs aux laboratoires PopInter (Paris 5) et CERPOS (Paris X) qui consitituent l'&#233;quipe d'accueil EA 2324. &lt;br class='autobr' /&gt;
Ce s&#233;minaire a &#233;galement &#233;t&#233; pr&#233;sent&#233; &#224; Conakry (Guin&#233;e), &#224; l'universit&#233; Paris 5, dans le cadre du DEA de sciences sociales de Paris 5 et &#224; l'Universit&#233; de Bourgogne, pendant l'ann&#233;e 2003/2004. &lt;br class='autobr' /&gt; Pr&#233;sentation des r&#233;sultats pr&#233;liminaires de l'enqu&#234;te Population Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime effectu&#233;e en janvier 2003.&#160;(&#8230;)&lt;/p&gt;


-
&lt;a href="https://www.joseph.larmarange.net/-Communications-" rel="directory"&gt;Communications&lt;/a&gt;

/ 
&lt;a href="https://www.joseph.larmarange.net/+-Connaissance-du-VIH-SIDA-+" rel="tag"&gt;Connaissance du VIH/SIDA&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Afrique-subsaharienne-+" rel="tag"&gt;Afrique subsaharienne&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Guinee-+" rel="tag"&gt;Guin&#233;e&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mortalite-+" rel="tag"&gt;Mortalit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Population-Pauvrete-Environnement-+" rel="tag"&gt;Population, Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Pauvrete-+" rel="tag"&gt;Pauvret&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Mortalite-infanto-juvenile-+" rel="tag"&gt;Mortalit&#233; infanto-juv&#233;nile&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Itineraires-therapeutiques-+" rel="tag"&gt;Itin&#233;raires th&#233;rapeutiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Monographies-de-village-+" rel="tag"&gt;Monographies de village&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Ressources-economiques-+" rel="tag"&gt;Ressources &#233;conomiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Activites-economiques-+" rel="tag"&gt;Activit&#233;s &#233;conomiques&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Fecondite-+" rel="tag"&gt;F&#233;condit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Migrations-+" rel="tag"&gt;Migrations&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Scolarisation-+" rel="tag"&gt;Scolarisation&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Nuptialite-+" rel="tag"&gt;Nuptialit&#233;&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Acces-aux-soins-+" rel="tag"&gt;Acc&#232;s aux soins&lt;/a&gt;, 
&lt;a href="https://www.joseph.larmarange.net/+-Milieu-rural-+" rel="tag"&gt;Milieu rural&lt;/a&gt;

		</description>


 <content:encoded>&lt;div class='rss_chapo'&gt;&lt;p&gt;Cette pr&#233;sentation s'inscrit dans les s&#233;minaires communs aux laboratoires PopInter (Paris 5) et CERPOS (Paris X) qui consitituent l'&#233;quipe d'accueil EA 2324.&lt;/p&gt;
&lt;p&gt;Ce s&#233;minaire a &#233;galement &#233;t&#233; pr&#233;sent&#233; &#224; Conakry (Guin&#233;e), &#224; l'universit&#233; Paris 5, dans le cadre du DEA de sciences sociales de Paris 5 et &#224; l'Universit&#233; de Bourgogne, pendant l'ann&#233;e 2003/2004.&lt;/p&gt;&lt;/div&gt;
		&lt;div class='rss_texte'&gt;&lt;p&gt;Pr&#233;sentation des r&#233;sultats pr&#233;liminaires de l'enqu&#234;te &lt;i&gt;Population Pauvret&#233; &amp; Environnement en Guin&#233;e Maritime&lt;/i&gt; effectu&#233;e en janvier 2003. Le texte accompagnant les diapositives est pr&#233;sent dans le fichier Power Point (imprimer pour cela les pages de commentaires).&lt;/p&gt;
&lt;p&gt;Mes &lt;a href='https://www.joseph.larmarange.net/Mortalite-infantile-Financement-de' class=&#034;spip_in&#034;&gt;m&#233;moires de DEA&lt;/a&gt; portent sur cette enqu&#234;te.&lt;/p&gt;&lt;/div&gt;
		
		</content:encoded>


		
		<enclosure url="https://www.joseph.larmarange.net/IMG/pdf/semi_ppe_2003.pdf" length="705637" type="application/pdf" />
		
		<enclosure url="https://www.joseph.larmarange.net/IMG/zip/ppoint_ppe2003.zip" length="4875144" type="application/zip" />
		

	</item>



</channel>

</rss>
